missing translation for 'onlineSavingsMsg'
Learn More
Learn More
ARNT/HIF-1 beta Antibody (H1beta234) - Azide and BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
Brand: Novus Biologicals NBP2-80582
This item is not returnable.
View return policy
Description
ARNT/HIF-1 beta Monoclonal specifically detects ARNT/HIF-1 beta in Human, Mouse, Rat, Bovine, Ferret, Primate, Sheep samples. It is validated for Western Blot, Chromatin Immunoprecipitation, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunoblotting, Gel Super Shift Assays.
Specifications
| ARNT/HIF-1 beta | |
| Monoclonal | |
| 1 mg/mL | |
| Western Blot 1:500 - 1:2000, Immunohistochemistry 1:100, Immunocytochemistry/Immunofluorescence reported in scientific literature (PMID 25343232), Immunoprecipitation, Immunohistochemistry-Paraffin 1:100, Immunoblotting 1:100 - 1:2000, Gel Super Shift Assays reported in scientific literature (PMID 11325839), Chromatin Immunoprecipitation (ChIP) 1:10-1:500 | |
| ARNT protein, aryl hydrocarbon receptor nuclear translocator, BHLHE2, HIF-1 Beta, HIF1B, HIF-1-beta, HIF1-beta, HIF1BETA, hypoxia-inducible factor 1, beta subunit, Hypoxia-inducible factor 1-beta, nuclear translocator | |
| Mouse | |
| Protein G purified | |
| RUO | |
| Primary | |
| Human, Mouse, Rat, Bovine, Ferret, Primate, Sheep | |
| Purified |
| Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation | |
| H1beta234 | |
| Unconjugated | |
| PBS | |
| ARNT | |
| Fusion protein containing amino acids 496-789 of human HIF-1 beta. [Uniprot: P27540] | |
| 0.1 mL | |
| Angiogenesis, Autophagy, Cancer, Cellular Markers, Chromatin Research, HIF Target Genes, Hypoxia, Transcription Factors and Regulators | |
| 405 | |
| Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles. | |
| IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction